title: The corticotropin-releasing factor receptor-2 mediates the motivational effect of opiate withdrawal.
abstract: Altered motivational processes are key features of drug dependence and withdrawal, yet their neural mechanisms remain largely unknown. The present study shows that genetic disruption of the corticotropin-releasing factor receptor-2 (CRF₂-/-) does not impair motivation for palatable food in drug-naïve mice. However, CRF₂ receptor-deficiency effectively reduces the increase in palatable food-driven motivation induced by opiate withdrawal. Indeed, both in male and female wild-type mice, withdrawal from escalating morphine doses (20-100 mg/kg) induces a dramatic and relatively long-lasting (6 days) increase in palatable food-driven operant behavior under a progressive ratio (PR) schedule of reinforcement. In contrast, either male or female morphine-withdrawn CRF₂-/- mice show smaller and shorter (2 days) increases in motivation than wild-type mice. Nevertheless, CRF₂ receptor-deficiency does not impair the ability to discriminate reinforced behavior prior to, during the partial opiate withdrawal periods occurring between morphine injections and following drug discontinuation, indicating preserved cognitive function. Moreover, CRF₂ receptor-deficiency does not affect the ambulatory or body weight effects of intermittent morphine injections and withdrawal. These results provide initial evidence of a gender-independent and specific role for the CRF₂ receptor in the motivational effects of opiate withdrawal.
authors.affiliation: Univ. Bordeaux, INCIA, UMR 5287, F-33000 Bordeaux, France.
authors.forename: Khalil
authors.initials: K
authors.lastname: Rouibi
authors.forename: Angelo
authors.initials: A
authors.lastname: Contarino
mesh_terms: D000818:Animals; D003216:Conditioning, Operant / Q000187:drug effects / Q000502:physiology; D004435:Eating / Q000187:drug effects / Q000502:physiology; D005260:Female; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology*; D009042:Motivation / Q000187:drug effects / Q000502:physiology*; D009154:Mutation; D018019:Receptors, Corticotropin-Releasing Hormone / Q000235:genetics / Q000502:physiology*; D012055:Reinforcement Schedule; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology* / Q000523:psychology
chemical_list: C101531:CRF receptor type 2; D018019:Receptors, Corticotropin-Releasing Hormone; D009020:Morphine
keywords: ANOVA; CRF; CRF(1); CRF(2); CRF(2) receptor; CTL; Corticotropin-releasing factor (CRF) system; Drug dependence; FR; Motivation; Null mutant mice; OW; Opiate withdrawal; PR; analysis of variance; control; corticotropin-releasing factor; corticotropin-releasing factor receptor-1; corticotropin-releasing factor receptor-2; fixed ratio; i.p.; intraperitoneally; opiate-withdrawn; progressive ratio